Menu

Denali Therapeutics Inc. (DNLI) Presents at Stifel 2026 Healthcare Conference 2026 Transcript
📰

Denali Therapeutics Inc. (DNLI) Presents at Stifel 2026 Healthcare Conference 2026 Transcript

All Articles on Seeking Alpha·3 days ago
#1SUqgBw8
#seekingalpha#paul#launch#scientific#officer
Reading 0:00
15s threshold

Denali Therapeutics Inc. ( DNLI ) Stifel 2026 Healthcare Conference 2026 November 11, 2026 9:20 AM EST

Company Participants

Joe Lewcock - Chief Scientific Officer

Conference Call Participants

Paul Matteis - Stifel Nicolaus Canada Inc., Research Division

Presentation

Paul Matteis

Stifel Nicolaus Canada Inc., Research Division

Thanks very much, everybody. Happy to be moderating this chat with Joe Lewcock, Chief Scientific Officer of Denali Therapeutics. I think we'll kick off and maybe hit a couple of questions on the AVLAYAH launch and how that's all going. And then I think we'll use this as an opportunity to maybe do a deeper dive into each pipeline program and preview some of the data readouts next year. But yes, thank you, Joe.

Question-and-Answer Session

Paul Matteis

Stifel Nicolaus Canada Inc., Research Division

So maybe to kick it off, like do you want to just level set for people and review the updates you gave on AVLAYAH in the past quarter?…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.